Skip to main content
OpenTrials
Enrolling by Invitation

NCT Number: NCT05433948

Diagnosing Minimal Hepatic Encephalopathy

Our purpose is to

1. Examine the correlation between MDF in a resting EEG, recorded just before the CRT test, and the variance in reaction times indicated by the CRT index 2. At simultaneous CRT and EEG recording, examine whether a change in EEG is seen immediately before an extended reaction time occurs (defined by the 75th percentile). This will shed light on a direct pathophysiological association between what is measured with EEG and CRT. 3. Investigate whether cyclicity can be detected in the continuous reaction times and if so, whether amplitude and wavelength in this cyclic activity are correlated to EEG parameters. 4. Examine whether a response to standard HE treatment can be detected with EEG in patients who are thought to suffer from it. As well as if baseline outcome predict future hepatic encephalopathy. 5. With a view to further validating our findings, investigators want to correlate results from EEG and CRT with the most internationally widespread psychometric test, the Portosystemic Encephalopathy test (PSE), which necessitates the establishment of Danish normal values. A secondary purpose of this study is therefore 6. To establish Danish normal values for the PSE test and the Animal Naming test in Danes

Enrolling by Invitation

Interested in participating?

Request Info

Key information

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

for patients with liver cirrhosis:

  • Age> 18
  • Liver cirrhosis verified by biopsy or appropriate clinic and biochemistry as well as imaging.
  • Written informed consent
  • Speaks and understands Danish

For the subgroup with liver cirrhosis and normal cognition:

  • Normal result in PSE and CRT testing and clinical examination without evidence of HE

For the subgroup with liver cirrhosis and minimal hepatic encephalopathy:

  • Abnormal result in PSE and / or CRT test, but oriented in time, place and own data.

For the subgroup with liver cirrhosis and HE grade 2, the following applies:

  • Abnormal PSE and CRT result and / or disoriented in time, place or own data and / or asterixis or other clinical symptoms of HE
  • Ability to collaborate on the performance of CRT test, PSE test and EEG

Inclusion criteria

healthy:

  • Liver healthy
  • Age over 18 years
  • Formal education ≤ 14 years
  • Written informed consent
  • Speaks and understands Danish

Inclusion criteria

for pre-cirrhosis liver disease:

As for healthy controls plus:

  • In our local outpatient clinic
  • Proven pre-cirrhosis liver disease

Exclusion criteria

  • Organic brain disease (eg previous epilepsy, apoplexy, dementia)
  • Hyponatraemia (Na <124 mmol / L)
  • Sepsis one week prior to tests.
  • Heart failure (EC less than 30% or NYHA class III and IV)
  • Severe chronic obstructive pulmonary disease (GOLD stage 3 and 4 ie FEV1 / FVC below 0.7 and FEV1 <50% of expected value)
  • Highly controllable diabetes (HbA1C> 60 mmol / mol)
  • Renal failure (eGFR below 60)
  • Known neurological diseases (epilepsy, stroke, dementia)
  • Intake of coffee or alcohol 6 hours before tests and change of dose in psychoactive drugs within 6 days of the test (morphine, antipsychotics, antidepressants) -

Treatment and study plan

Simultaneous EEG and CRT

Diagnostic Test

EEG is recorded with 32 electrodes and commercial recording equipment.10 min EEG is recorded in idle mode with eyes closed prior to continuous EEG recording during the CRT examination, see below.

The test is performed via a laptop using EKHO software. The software generates 150 sound stimuli of 90 dB, which the patient hears in sound-insulated headphones. Via a push button in the dominant hand, the patient must respond as quickly as possible as soon as sounds are perceived.

PSE test: Duration 20 min. Includes 5 tasks: Digit-symbol Test, Number Connecting Test A, Number Connecting Test B, Serial Dotting Test and Line Tracing Test. Exits in 4 versions, which are used in repeated tests to avoid the learning effect. Scores range from -18 t0 6 and less -4 is abnormal.

Other names: PSE test, Animal Naming Test

Primary outcomes

  1. Concordant changes in reaction times and in EEG spectral and frequency analysis

    Time frame: Up to 60 months

    During CRT 150 reaction times are measured. Investigators want to measure if prolonged reaction times >75 percentile are preceded by spectral and frequency changes in EEG. For EEG investigators will assess relative theta and delta activity. EEG and CRT will be done simultaneously.

  2. Observation of cyclic activity in continous reaction times (CRT measures)

    Time frame: Up to 60 months

    Apply mathematically modeled time analysis to establish cyclicity in the 150 measures reaction times and examine if cyclic activity correlates to relative theta and delta activity in the EEG.

  3. Change in EEG spectral and frequency analysis with a clinically indicated standard treatment for minimal hepatic encephalopathy

    Time frame: Up to 60 months

    Some patients will be found eligible for treatment with lactulose or rifaximin due to signs of minimal hepatic encephalopathy. Investigators will use EEG relative theta and delta activity to measure the efficacy of the treatment.

Sponsors and collaborators

Lead sponsor

Esbjerg Hospital - University Hospital of Southern Denmark

Other

Collaborators

  • Aalborg University Hospital
  • Herlev Hospital
  • Regionshospitalet Silkeborg

Registry information

Official study title

Diagnostik Af Minimal Hepatisk Encephalopati: Association Mellem Kontinuert Reaktionsstidsmåling Og EEG-indices

Acronym: MindTheLiver

Important dates

Study start
2019
Primary completion
2026
Study completion
2031
First posted
Jun 27, 2022
Registry last updated
Dec 2, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.